This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Csl Behring Gmbh. Active years: 2017-2022.
Company Filing History:
Years Active: 2017-2022
Title: Jeffrey Michael Hey: Innovator in Protein Depletion Technologies
Introduction
Jeffrey Michael Hey is a notable inventor based in Hurstbridge, Australia. He has made significant contributions to the field of protein depletion technologies, holding a total of 3 patents. His work focuses on innovative methods for reducing specific proteins in various solutions, which has important implications in pharmaceutical formulations.
Latest Patents
Hey's latest patents include groundbreaking inventions such as the "Hydrophobic charge induction chromatographic protein depleted solution." This invention relates to a method aimed at reducing the levels of proteins like plasminogen and tissue plasminogen activator in solutions containing fibrinogen, Factor VIII, and von Willebrand factor (VWF). The method not only enhances the purity of these solutions but also provides pharmaceutical formulations that utilize the recovered proteins.
Another significant patent is the "Hydrophobic charge induction chromatographic depletion of a protein from a solution." This invention outlines a process where a feedstock containing proteins is passed through a specialized chromatographic resin. This process effectively reduces the concentration of unwanted proteins by at least 50%, thereby improving the quality of the resulting solution.
Career Highlights
Jeffrey Hey is currently associated with CSL Behring GmbH, a leading global biotechnology company. His role involves developing innovative solutions that enhance the efficacy of therapeutic proteins. His expertise in protein chemistry and chromatography has positioned him as a key player in the field.
Collaborations
Throughout his career, Hey has collaborated with talented professionals, including Darren Nguy and Hung Pham. These collaborations have fostered a creative environment that encourages the development of cutting-edge technologies in protein depletion.
Conclusion
Jeffrey Michael Hey's contributions to the field of protein depletion are noteworthy and impactful. His innovative patents and collaborations continue to advance the science of protein purification, benefiting the pharmaceutical industry and beyond.